The global newborn screening market size was US$ 1.1 billion in 2021. The global newborn screening market size is forecast to reach US$ 2.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period from 2022 to 2030.
Newborn screening detects conditions that may have a long-term impact on a child's health or survival. This screening method consists of a battery of tests that are necessary for early identification, diagnosis, and health care in order to prevent overall handicap and a child's death. These tests reveal genetic, developmental, and metabolic problems in newborn babies and are conducted shortly after the baby is delivered. Prior to discharge from a hospital or birthing facility, a few drops of blood from the newborn's heel are tested for specific genetic, endocrine, metabolic diseases, hearing loss, and catastrophic congenital heart abnormalities (CCHDs).
Factors Influencing Market Growth
Impact Analysis of COVID-19
COVID-19 pandemic negatively affected the global newborn screening market. Due to mail delays, unreliability, and airline cancellation, samples arriving at screening locations and the availability of laboratory equipment and reagents had delayed. Laboratory personnel availability had to occasionally reduce due to infection, quarantine, or relocation within the healthcare center. Samples at home collection, second-tier tests, and follow-up were all affected. Social restrictions and public transportation delays exacerbated these problems. Only a few centers were maintaining full operation of their NBS (newborn screening) programs.
Regional Insights
North America garnered the major market share in 2021 and is forecast to maintain its position during the forecast period. As a result of the easy availability of newborn screening programs, profitable reimbursement policies, and substantial market participant presence.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing population rates, rising birth rates, and an increase in congenital disease cases.
Leading Competitors
The leading prominent companies profiled in the global newborn screening market are:
Scope of the Report
The global newborn screening market segmentation focuses on Product Type, Test Type, Technology, End-User, and Region.
Segmentation based on Product Type
Segmentation based on Test Type
Segmentation based on Technology
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL NEWBORN SCREENING MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL NEWBORN SCREENING MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 INSTRUMENTCONSUMABLES
6 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE
6.1 OVERVIEW
6.2 BLOOD TEST
6.3 HEARING SCREENING TEST
6.4 HEART SCREENING
7 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 TANDEM MASS SPECTROMETRY (TMS)
7.3 MOLECULAR ASSAYS
7.4 IMMUNOASSAYS AND ENZYMATIC ASSAYS
7.5 HEARING SCREEN TECHNOLOGY
7.6 PULSE OXIMETRY SCREENING TECHNOLOGY
7.7 OTHERS
8 GLOBAL NEWBORN SCREENING MARKET, BY END-USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 CLINICAL LABORATORIES
9 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3. 1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL NEWBORN SCREENING MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
11 COMPANY PROFILES
11.1 AB SCIEX LLC
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 AGILENT TECHNOLOGIES INCORPORATED
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 BIO-RAD LABORATORIES INCORPORATED
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 COVIDIEN PLC
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 GE HEALTHCARE
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 PERKINELMER INCORPORATED
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.7 MASIMO CORPORATION
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.8. NATUS MEDICAL INCORPORATED
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.9 TRIVITRON HEALTHCARE
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.10 WATERS CORPORATION
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved